<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

Past speakers


Innovation across biotech, medtech and healthtech

Ariana Adjani, Co-Founder, Fine Treatment

Ariana Adjani

Co-Founder
Fine Treatment
John Lee Allen, Managing Partner, RYSE Asset Management

John Lee Allen

Managing Partner
RYSE Asset Management
Renee Aguiar-Lucander, CEO, Calliditas Therapeutics

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Khatereh Ahmadi, Head of Search and Evaluation Europe and Middle East BD&L Team, MSD Ltd

Khatereh Ahmadi

Head of Search and Evaluation Europe and Middle East BD&L Team
MSD
Mehdi Ainouche, Principal, Jeito

Mehdi Ainouche

Principal
Jeito
Mike Alavarez, CEO, Qardio

Mike Alavarez

CEO
Qardio
Michael Altorfer, Chief Executive Officer, Swiss Biotech Association

Michael Altorfer

Chief Executive Officer
Swiss Biotech Association
Madeleine Armstrong, News Editor, Evaluate

Madeleine Armstrong

News Editor
Evaluate
Derk Arts, CEO, Castor

Derk Arts

CEO
Castor
David Atkins, Chief Executive Officer, Congenica

David Atkins

Chief Executive Officer
Congenica
Assaf Barnea, CEO, Sanara Ventures

Assaf Barnea

CEO
Sanara Ventures
Simon Basham, Head of Cyber & TMT Broking UK, WTW

Simon Basham

Head of Cyber & TMT Broking UK
WTW
Mats Berggren, Head of Digital Growth Opportunities and Innovation, Merck

Mats Berggren

Head of Digital Growth Opportunities and Innovation
Merck
Xavier Bertrand, VP & GM EMEA Healthcare Services and Alliances, Boston Scientific

Xavier Bertrand

VP & GM EMEA Healthcare Services and Alliances
Boston Scientific
Maina Bhaman, Partner, Sofinnova Partners

Maina Bhaman

Partner
Sofinnova Partners
Robin Bhattacherjee, CEO, Actimed Therapeutics

Robin Bhattacherjee

CEO
Actimed Therapeutics
Martin-Immanuel Bittner, CEO, Arctoris

Martin-Immanuel Bittner

CEO
Arctoris
Bernd Boidol, CEO, Proxygen

Bernd Boidol

CEO
Proxygen
Georg Bortlein, CEO, Highlife Medical

Georg Bortlein

CEO
Highlife Medical
Jasper Bos, General Partner, Forbion; CEO, Forbion European Acquisition

Jasper Bos

General Partner, Forbion
CEO, Forbion European Acquisition
Peter Bowness, Director, International Regulatory Affairs, MCRA; Former Senior Regulator, BSI

Peter Bowness

Director, International Regulatory Affairs, MCRA
Former Senior Regulator, BSI
Viola Bronsema, CEO and Secretary General, BIO Deutschland

Viola Bronsema

CEO and Secretary General
BIO Deutschland
Seamus Browne, Head of Industry Partnerships, Royal College of Surgeons in Ireland

Seamus Browne

Head of Industry Partnerships
Royal College of Surgeons in Ireland
Roel Bulthuis, Managing Director, INKEF Capital

Roel Bulthuis

Managing Director
INKEF Capital
Drew Burdon, Investment Manager, LSP

Drew Burdon

Partner
EQT Life Sciences
Elizabeth Cairns, Medtech Reporter, Vantage

Elizabeth Cairns

Medtech Reporter
Vantage
Jose Calle Gordo, Operating Partner, Valiance

Jose Calle Gordo

Managing Partner
Valiance
Brittanie Campbell, Account Executive, Greenlight Guru

Brittanie Campbell

Account Executive
Greenlight Guru
Matt Cardinal, VP Strategy & Program Leadership, Halloran

Matt Cardinal

VP Strategy & Program Leadership
Halloran
Björn Carlsson, Advisory Board Member, NDA Group

Björn Carlsson

Principal Consultant & Advisory Board Member
NDA Group
Steve Carney, Editor, Drug Discovery Today

Steve Carney

Editor
Drug Discovery Today
John Cassidy, Investment Director Life Sciences & HealthTech, Softbank Vision Fund

John Cassidy

Investment Director Life Sciences & HealthTech
Softbank Vision Fund
Richard Cassidy, VP Rx+Global, Astellas Pharma

Richard Cassidy

SVP Rx+ Business Accelerator
Astellas Pharma
Chris Chamberlain, Executive Director Experimental Medicine, AstraZeneca

Chris Chamberlain

Executive Director Experimental Medicine
AstraZeneca
Alexander Chekan, Chief of Staff, Palta

Alexander Chekan

Chief of Staff
Palta
Djork-Arne Clevert, Director Machine Learning, Bayer

Djork-Arne Clevert

Director Machine Learning
Bayer
Megan Coder, Vice President of Global Policy, Digital Therapeutics Alliance

Megan Coder

Vice President of Global Policy
Digital Therapeutics Alliance
Jean-Philippe Combal, CEO, Vivet Therapeutics

Jean-Philippe Combal

CEO
Vivet Therapeutics
Yuehua Cong, BD Executive Director, Simcere Pharmaceutical Group

Yuehua Cong

BD Executive Director
Simcere Pharmaceutical Group
Juliette Cook, Vice President Quality and Regulatory Affairs, Implantica Management AG

Juliette Cook

Vice President Quality and Regulatory Affairs
Implantica Management AG
Jette Cowan, Head Of Commercial – Pharmaceuticals, RSSL

Jette Cowan

Head Of Commercial – Pharmaceuticals
RSSL
Sarah Cowlishaw, Partner, Covington & Burling

Sarah Cowlishaw

Partner
Covington & Burling
Ian Coyne, Consulting Partner, Coulter Partners

Ian Coyne

Executive Director Global Information & Intelligence
Coulter Partners
David Crome, Managing Director Compliance UK, ProPharma Group

David Crome

Managing Director Compliance UK
ProPharma Group
Ian Crosbie, CEO, Sequana Medical NV

Ian Crosbie

CEO
Sequana Medical NV
Maria Dahl, Chief Operating Officer and Head, Europe, Innovent Biologics

Maria Dahl

Chief Operating Officer and Head, Europe
Innovent Biologics
Victoria Darbyshire, Equity Analyst, J.P. Morgan

Victoria Darbyshire

Equity Analyst
J.P. Morgan
Nach Dave, Vice President Development Strategy, Premier Research

Nach Dave

Vice President Development Strategy
Premier Research
Mark Davies, SVP of Informatics and Data, Benevolent AI

Mark Davies

SVP of Informatics and Data
BenevolentAI
Mark Davies, Chief Medical Officer EMEA, IBM Watson Health

Mark Davies

Chief Medical Officer EMEA
IBM Watson Health
John Dawson, CEO, Oxford Biomedica

John Dawson

Director
Oxford Biomedica
Lucas de Breed, Founder, August

Lucas de Breed

Founder
August
Hamman de Vaal, Chief Commercial Officer, AdjuCor

SPEAKER NAME

Job, Designation
- BIOTECH AND MONEY
Ros Deegan, CEO, OMass Therapeutics

Ros Deegan

CEO
OMass Therapeutics
Graham Defries, Partner, Goodwin

Graham Defries

Partner
Goodwin
Christian Dillon​, CSO, Phoremost

Christian Dillon

CSO
Phoremost
Suzanne Dilly, CEO, ValiRx

Suzanne Dilly

CEO
ValiRx
Guy Dingley, Partner, Covington & Burling

Guy Dingley

Partner
Covington & Burling
Mark Dorff, Partner, Brown Rudnick

Mark Dorff

Partner
Brown Rudnick
Angela Drew, Director Regulatory Strategy, Premier Consulting

Angela Drew

Director Regulatory Strategy
Premier Consulting
Jonathan Edgeworth, Consultant Microbiologist and Infectious Disease Clinician, Guys and St Thomas NHS Foundation Trust

Jonathan Edgeworth

Consultant Microbiologist and Infectious Disease Clinician
Guys and St Thomas NHS Foundation Trust
Abie Ekangaki, Vice President, Statistical Consulting, Premier Research

Abie Ekangaki

Vice President, Statistical Consulting
Premier Research
Annemijn Eschauzier, Mentor; former CMO Women's Health, GE

Annemijn Eschauzier

Mentor
former CMO Women's Health, GE
Peter Finnie, Partner, Potter Clarkson

Peter Finnie

Partner
Potter Clarkson
Rachel Ford Hutman, Founder and CEO, Ford Hutman Media

Rachel Ford Hutman

Founder and CEO
Ford Hutman Media
Beth Fordham-Meier, VP Business Development, Cello Health BioConsulting 300x

Beth Fordham-Meier

VP, Business Development, BioConsulting
Lumanity
Jason Foster, CEO, Ori Biotech

Jason Foster

CEO
Ori Biotech
Zina Fragkiadaki, Senior Reporter, HealthInvestor UK

Zina Fragkiadaki

Senior Reporter
HealthInvestor UK
Hayley French, former CEO, Apitope

Hayley French

Investor
Vesalius Biocapital Partners
Matt Fujisawa, Global Head of Corporate Development, KRY

Matt Fujisawa

Global Head of Corporate Development
KRY
Marta Gaia Zanchi, Founder and Managing Partner, Nina Capital

Marta Gaia Zanchi

Founder and Managing Partner
Nina Capital
Robert Garber, Partner, 7Wire Ventures

Robert Garber

Partner
7WireVentures
Neil Gomes, System SVP, Digital Human Experiences, Common Spirit Health

Neil Gomes

System SVP, Digital Human Experiences
Common Spirit Health
Lala Gregorek, Healthcare Analyst, Trinity Delta

Lala Gregorek

Healthcare Analyst
Trinity Delta
Franc Gregori, Analyst, Trinity Delta

Franc Gregori

Analyst
Trinity Delta
Gregoire Guillet, Chief Business & Value Officer – WeHealth Digital Medicine, Servier

Gregoire Guillet

Chief Business & Value Officer – WeHealth Digital Medicine
Servier
Andrew Hack, Managing Director, Bain Capital Life Sciences

Andrew Hack

Managing Director
Bain Capital Life Sciences
Sofia Håkansson Buch, VP Stem Cell CMC & Manufacturing, Novo Nordisk

Sofia Håkansson Buch

VP Cell Therapy CMC
Novo Nordisk
Brian Hakim, Director Business Development, MedTecX

Brian Hakim

Director Business Development
MedTecX
James Halstead, Partner, Covington & Burling

James Halstead

Partner
Covington & Burling
Alex Hamilton, Partner, Syncona

Alex Hamilton

Partner
Syncona
Giles Hamilton, CEO, ODx Innovations

Giles Hamilton

CEO
ODx Innovations
Luke Hares, CTO, CMR Surgical

Luke Hares

CTO
CMR Surgical
Deborah Harland, Partner, SR One

Deborah Harland

Partner
SR One
Mike Harris, CEO, Biocomposites

Mike Harris

CEO
Biocomposites
Steven Harris, Chairman, CS Pharmaceuticals

Steven Harris

Chairman
CS Pharmaceuticals
Andrew Harrow, Partner, Goodwin

Andrew Harrow

Partner
Goodwin
Ali Hasan, Chief Medical & Healthcare Officer, Vitality

Ali Hasan

Chief Medical & Healthcare Officer
Vitality
Bill Haynes, Head of Novo Nordisk Research Centre Oxford, Novo Nordisk

Bill Haynes

Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Brian Heaphy, SVP, Head of Corporate Development, Strategy & Business Development, BMS

Brian Heaphy

SVP, Corporate Development
BMS
Christian Hein, VP Global Head of Digital Transformation & Innovation Execution, Novartis

Christian Hein

VP Global Head of Digital Transformation & Innovation Execution
Novartis
Zach Henderson, Chief Commercial Officer, Glooko

Zach Henderson

Chief Commercial Officer
Glooko
Valerie Hepp, Digital and PHC Partnering Europe, Roche

Valerie Hepp

Digital and PHC Partnering Europe
Roche
Carl Hewett, Head of Medical Design Innovation, Sagentia Innovation

Carl Hewett

Head of Medical Design Innovation
Sagentia Innovation
Andrew Hill, Product Innovation Lead, Willis Towers Watson

Andrew Hill

Product Innovation Lead
WTW
Berthold Hinzen, Head of BD&L Therapeutic Areas, Bayer

Berthold Hinzen

Head of BD&L Therapeutic Areas
Bayer
Regina Hodits, Managing Partner, Wellington Partners

Regina Hodits

Managing Partner
Wellington Partners
Ben Hohn, Principal - BD, Pipeline and Launch Strategy & Emerging Pharma Lead, ZS Associates, Inc

Ben Hohn

Principal - BD, Pipeline and Launch Strategy & Emerging Pharma Lead
ZS Associates, Inc
Asaf Homossany, Senior Managing Director - EMEA, Nasdaq

Asaf Homossany

Senior Managing Director - EMEA
Nasdaq
Anne Horgan, Partner, Cambridge Innovation Capital

Anne Horgan

Partner
Cambridge Innovation Capital
Baudouin Hue, Partner, Karista

Baudouin Hue

Partner
Karista
Patrick Hughes, Director, Advisory Services EMEA, Nasdaq

Patrick Hughes

Director, Advisory Services EMEA
Nasdaq
Thomas Hummel, Head of Strategy and Innovation, Digital Health, Siemens Healthineers

Thomas Hummel

Digital Transformation Corporate Development
Fresenius Kabi
Wen Hwa Lee, CEO and Chief Scientist, Action Against AMD (Hehim)

Wen Hwa Lee (He/him)

CEO and Chief Scientist
Action Against AMD
Sofia Ioannidou, Partner, Andera Partners

Sofia Ioannidou

Partner
Andera Partners
Catherine Isted, CFO, ReNeuron

Catherine Isted

CFO
ReNeuron
Pierre-Louis Joffrin, CDO, Mogrify

Pierre-Louis Joffrin

CDO
Mogrify
Fredrik Johansson, CFO, Calliditas Therapeutics

Fredrik Johansson

CFO
Calliditas Therapeutics
Marc Julien, CEO, Diabeloop

Marc Julien

CEO
Diabeloop
Markus Kalousek, Global Head of Pharma S&E, Novartis

Markus Kalousek

Global Head Search & Evaluation
Novartis
Tahera Kan, VP Transactions, Johnson & Johnson Innovation EMEA

Tahera Kan

VP Transactions, Johnson & Johnson Innovation EMEA
Johnson & Johnson
Christoph Kausch, Managing Partner, MTIP

Christoph Kausch

Managing Partner
MTIP
Oliver Keown, Director, Intuitive Ventures

Oliver Keown

Managing Director
Intuitive Ventures
Maya Khurana, Health and Life Sciences Director, Oliver Wyman

Maya Khurana

Health and Life Sciences Director
Oliver Wyman
Robert Kieval, Chief Executive Officer, IMMR (now part of Veranex)

Robert Kieval

EVP Strategic Partnerships
Veranex
Sven Kili, Chief Executive Officer, Antion Biosciences SA

Sven Kili

Chief Executive Officer
Antion Biosciences SA
Jan Kimpen, Chief Medical Officer, Philips

Jan Kimpen

Chief Medical Officer
Philips
Linda Korthout, Director International Clinical Affairs, MCRA

Linda Korthout

Director International Clinical Affairs
MCRA
Charity Kufaas, VP, Strategy & Business Development EMEA, Medtronic

Charity Kufaas

VP, Strategy & Business Development EMEA
Medtronic
Dima Kuzmin, Managing Director, 4BIO Capital

Dima Kuzmin

Managing Director
4BIO Capital
Paul Landau, CEO, Careology

Paul Landau

CEO
Careology
Werner Lanthaler, CEO, Evotec

Werner Lanthaler

CEO
Evotec
Stephanie Leouzon, Partner, Torreya

Stephanie Léouzon

Partner
Torreya
Marta Helena Lesko, Head of BD Enabling Technologies, Merck KGaA

Marta Helena Lesko

Head of BD Enabling Technologies
Merck KGaA
Sergio Levi, Vice President Strategic Alliances, Philips

Sergio Levi

Vice President Strategic Alliances
Philips
Bruce Lichorowic, President & CEO, Galen Robotics

Bruce Lichorowic

President & CEO
Galen Robotics
Angela Liedler, Managing Director, Precisis

Angela Liedler

Managing Director
Precisis
Peter Llewellyn-Davies, CEO, APEIRON

Peter Llewellyn-Davies

CEO
invIOs
Rana Lonnen, Head of Search and Evaluation, Strategic Capital, Novartis

Rana Lonnen

Managing Director, dRx Capital
Novartis
Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

VP Venture Science, Corporate BD
Eli Lilly
Nanna Lüneborg, General Partner, Forbion

Nanna Lüneborg

General Partner
Forbion
Franklin Maddux, Global CMO, Fresenius Medical Care

Franklin Maddux

Global CMO
Fresenius Medical Care
Priya Mande, Interim CEO, PsiOxus Therapeutics

Priya Mande

Interim CEO
PsiOxus Therapeutics
Guy Martin, Deputy Editor, Pharma Letter

Guy Martin

Deputy Editor
Pharma Letter
Anton Mat, Director of Business Development, ISA Pharmaceuticals

Anton Mat

Director of Business Development
ISA Pharmaceuticals
Giuseppe Mazza, CEO, Engitix Therapeutics

Giuseppe Mazza

CEO
Engitix Therapeutics
Jessica McCreadie, Principal, Octopus Ventures

Jessica McCreadie

Principal
Octopus Ventures
Robbie McLaren, Partner, Latham & Watkins

Robbie McLaren

Partner
Latham & Watkins
Anita Meiklejohn, Principal, Fish & Richardson

Anita Meiklejohn

Principal
Fish & Richardson
Jason Mellad, CEO, Start Codon

Jason Mellad

CEO
Start Codon
Lisa Melton, Senior News Editor, Nature Biotechnology

Lisa Melton

Senior News Editor
Nature Biotechnology
John Milad, CEO, Quanta Dialysis Technologies

John Milad

CEO
Quanta Dialysis Technologies
Tim Mitchell, VP Strategic Programs, NAMSA

Tim Mitchell

VP Strategic Programs
NAMSA
Piers Morgan, CEO, Cellcentric

Piers Morgan

CFO
Cellcentric
Tim Morris, COOCFO, Humanigen

Tim Morris

COO/CFO
Humanigen
Parker Moss, Chief Commercial Officer, Genomics England

Parker Moss

Chief Commercial Officer
Genomics England
Rachel Moss, Partner, McKinsey

Rachel Moss

Partner
McKinsey
Jukka Muhonen, Director of Global Business Development and Alliance Management, Orion Corporation

Jukka Muhonen

Director of Global Business Development and Alliance Management
Orion Corporation
Matthias Müllenbeck, Senior Vice President and Head of Global Business Development & Alliance Management, Merck KGaA

Matthias Müllenbeck

Senior Vice President and Head of Global Business Development & Alliance Management
Merck KGaA
Arif Nathoo, CEO, Komodo Health

Arif Nathoo

CEO
Komodo Health
Michael Niddam, Co-Founder, Kamet Ventures 300x

Michael Niddam

Co-Founder & Managing Director
Kamet Ventures
Laura Niklason, CEO, Humacyte

Laura Niklason

CEO
Humacyte
David Norton, Senior Lead Innovation Consultant, Royal Free London Foundation Trust

David Norton

Senior Lead Innovation Consultant
Royal Free London Foundation Trust
Caroline Noublanche, CEO, Apricity

Caroline Noublanche

CEO
Apricity
Markus Ott, Head Global Market Access & Health Policy, Roche

Markus Ott

Head Global Market Access & Health Policy
Roche
Tej Panesar, Investment Director - Life Sciences, British Patient Capital

Tej Panesar

Investment Director - Life Sciences
British Patient Capital
Francis Pang, VP Global Market Access, Orchard Therapeutics

Francis Pang

VP Global Market Access
Orchard Therapeutics
Pierluigi Paracchi, CEO, Genenta Biosciences

Pierluigi Paracchi

CEO & Co-founder
Genenta Science
Sokratis Papafloratos, CEO, Numan

Sokratis Papafloratos

CEO
Numan
Nick Pattinson, Head of Product, Automata

Nick Pattinson

Head of Product
Automata
Antoine Pau, Senior Partner, Truffle Capital

Antoine Pau

Senior Partner
Truffle Capital
Morag Peberdy, Of Counsel, Covington & Burling

Morag Peberdy

Of Counsel
Covington & Burling
Elisa Petris, Partner, Syncona

Elisa Petris

Partner
Syncona
Martin Pfister, Investment Manager, High-Tech Gründerfonds

Martin Pfister

Principal
HTGF
Jim Polson, Managing Director, FTI Consulting

Jim Polson

Managing Director
FTI Consulting
Rebecca Pope (sheher), UK Digital & Data Science Innovation Lead, Roche

Rebecca Pope (she/her)

UK Digital & Data Science Innovation Lead
Roche Products
Steven Powell, CEO, eTheRNA immunotherapies

Steven Powell

CEO
eTheRNA immunotherapies
Cody Powers, Principal, ZS Associates

Cody Powers

Principal
ZS Associates
Lord David Prior, Chairman, NHS

Lord David Prior

Former Chair, NHS England;
Global Senior Advisor, Lazard; Chair, Cambridge Life Sciences Council
Tony Proctor, Partner, Potter Clarkson

Tony Proctor

Partner
Potter Clarkson
Gil Rabbie, Digital Solutions & Capability Development Leader, Boston Scientific

Gil Rabbie

Digital Solutions & Capability Development Leader
Boston Scientific
Marc Ramis Castelltort, CEO, Rejuversen 300x

Marc Ramis Castelltort

Venture Partner
Chasing Science
Nazar Rasul, VP Global Head of Digital, Fresenius Kabi

Nazar Rasul

VP Global Head of Digital
Fresenius Kabi
Tara Raveendran, Head of Healthcare & Life Sciences Research, Polar Capital

Tara Raveendran

Head of Healthcare & Life Sciences Research
Polar Capital
Bleddyn Rees, Chair, The Digital Health Society; Board Director, ECHAlliance

Bleddyn Rees

Chair, The Digital Health Society
Board Director, ECHAlliance
Stephen Reese, Partner, Clifford Chance

Stephen Reese

Partner
Clifford Chance
Brad Robling, VP Corporate Business Development, Eli Lilly

Brad Robling

VP, Lilly Ventures, Corporate BD
Eli Lilly
Chris Robson, CEO, Living With

Chris Robson

CEO
Living With
Andrew Roddam, CEO, Our Future Health

Andrew Roddam

CEO
Our Future Health
Hanno Ronte, Partner, Monitor Deloitte

Hanno Ronte

Partner
Monitor Deloitte
Kieran Rooney, VP, Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP, Strategic Alliances and Licensing
Amryt Pharma
Chris Rowe, Innovation Lead, Innovate UK

Chris Rowe

Innovation Lead
Innovate UK
Laurie Rowe, Director & Founder, RED Medtech

Laurie Rowe

Director & Founder
RED Medtech
John Rudy, Member, Mintz

John Rudy

Member
Mintz
Igor Rudychev, VP Enterprise Analytics, Horizon Therapeutics

Igor Rudychev

VP Enterprise Analytics
Horizon Therapeutics
Gunnar Sachs, Partner, Clifford Chance

Gunnar Sachs

Partner
Clifford Chance
Neil Sahota, United Nations Artificial Intelligence Advisor & Interim CEO, ACSILabs

Neil Sahota

United Nations Artificial Intelligence Advisor & Interim CEO
ACSILabs
Ed Saltzman, Executive Chairman, Cello Health BioConsulting

Ed Saltzman

Head, Biotech Strategy
Lumanity
Antonio Sanchez-Cordero, WW VP Business Development & Strategy, Becton Dickinson

Antonio Sanchez-Cordero

WW VP Business Development & Strategy
Becton Dickinson
Arthur Sands, CEO, Nurix Inc.

Arthur Sands

CEO
Nurix Inc.
Josep Sanfeliu, Co-Founder and Managing Partner, Asabys Partners-1

Josep Sanfeliu

Managing Partner
Asabys
Diana Saraceni, Managing Partner, Panakès Partners

Diana Saraceni

Managing Partner
Panakès Partners
Fabian Scheugenpflug, Senior Ventures Associate, Startup Creasphere powered by Plug and Play

Fabian Scheugenpflug

Senior Ventures Associate
Startup Creasphere powered by Plug and Play
Isabella Schidrich, Senior Managing Director, Nasdaq

Isabella Schidrich

Senior Managing Director
Nasdaq
Susanne Schorsch, Vice President Business Development, Comphya

Susanne Schorsch

Vice President Business Development
Comphya
Eliane Schutte, Chief Executive Officer, Xeltis B.V.

Eliane Schutte

Chief Executive Officer
Xeltis B.V.
Sara Secall, Investment Director & Partner, Inveready Asset Management 300x

Sara Secall

Partner
Inveready
Graziano Seghezzi, Managing Partner, Sofinnova

Graziano Seghezzi

Managing Partner
Sofinnova
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Tom Shepherd, CEO, Captor Therapeutics

Tom Shepherd

CEO
Captor Therapeutics
João Siffert, CEO & President, Design Therapeutics

João Siffert

CEO & President
Design Therapeutics
Tobias Silberzahn, Partner, McKinsey

Tobias Silberzahn

Partner
McKinsey
Ari Silverman, Partner, Mavie Technologies

Ari Silverman

Partner
Mavie Technologies
Stephanie Sirota, Partner and Chief Business Officer, RTW Investments

Stephanie Sirota

Partner and Chief Business Officer
RTW Investments
Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience

Ulrica Slåne Bjerke

CIO
Arctic Aurora LifeScience
Mark Slaughter, SVP Business Development, Sidekick Health

Mark Slaughter

SVP Business Development
Sidekick Health
Rhoda Steel, Head of Community Impact, Johnson & Johnson UK

Rhoda Steel

Head of Community Impact
Johnson & Johnson UK
Anette Steenberg, CEO, Medicon Valley Alliance

Anette Steenberg

CEO
Medicon Valley Alliance
Jérôme Stevens, Managing Director, Webhelp Medica

Jérôme Stevens

General Manager & co-founder
Webhelp Medica
Johan Strömquist, CEO, NDA Group

Johan Strömquist

CEO
NDA Group
Tina Tan, Executive Editor, FirstWord HealthTech

Tina Tan

Executive Editor
FirstWord HealthTech
Susan Thomas, Clinical Director, Google Health UK

Susan Thomas

Clinical Director
Google Health UK
Nicki Thompson, CEO, Amphista Therapeutics

Nicki Thompson

CEO
Amphista Therapeutics
Steve Tolle, Partner, HLM Ventures

Steve Tolle

Partner
HLM Ventures
Gadi Toren, Investment Partner, Robert Bosch Venture Capital

Gadi Toren

Investment Partner
Robert Bosch Venture Capital
Carina Tyrell, Chief of Staff & Investment Associate, Walden Catalyst Ventures

Carina Tyrell

Chief of Staff & Investment Associate
Walden Catalyst Ventures
Andrew Udell, President, North America, Calliditas Therapeutics

Andrew Udell

President, North America
Calliditas Therapeutics
Dan Vahdat, CEO, Huma

Dan Vahdat

CEO
Huma
Caoimhe Vallely-Gilroy, Head of Digital Health & Therapeutics, Healthcare Business of Merck KGaA

Caoimhe Vallely-Gilroy

Head of Digital Health & Therapeutics
Healthcare Business of Merck KGaA
Josh Valman, CEO, RPD International

Josh Valman

CEO
RPD International
Valerie Vanhooren, CEO, ONA Therapeutics

Valerie Vanhooren

CEO & Co-Founder
ONA Therapeutics
Erik van den Berg, CEO, AM Pharma

Erik van den Berg

CEO
AM Pharma
Sally Van Kooten, VP Commercial Strategy, Kalvista

Sally van Kooten

VP Commercial Strategy
KalVista Pharmaceuticals
Edward van Wezel, Managing Partner, Biogeneration Ventures

Edward van Wezel

Managing Partner
Biogeneration Ventures
Bonnie van Wilgenburg, Principal, Monograph Capital Partners

Bonnie van Wilgenburg

Principal
Monograph Capital Partners
Wilfred Van Zuilen, President EMEA, Zimmer Biomet

Wilfred Van Zuilen

President EMEA
Zimmer Biomet
Laurent Vandebrouck, CEO, Chronolife

Laurent Vandebrouck

CEO
Chronolife
Per Vegard Nerseth, CEO, CMR Surgical

Per Vegard Nerseth

CEO
CMR Surgical
Neil Ward, VP EMEA, Pacific Bioscience

Neil Ward

VP EMEA
Pacific Biosciences
Pnina Weitz, Global Head of Venture Capital Business Development & Relationship Management, Lonza

Pnina Weitz

Global Head of Venture Capital Business Development & Relationship Management
Lonza
Ethan Wergelis-Isaacson, Digital Health Strategy, Otsuka

Ethan Wergelis-Isaacson

Digital Health Strategy
Otsuka
Jacob West, Director, Healthcare & Life Sciences, Microsoft

Jacob West

Director, Healthcare & Life Sciences
Microsoft
Nicklas Westerholm, CEO, Egetis Therapeutics

Nicklas Westerholm

CEO
Egetis Therapeutics
Cyndi Williams, CEO, Quin

Cyndi Williams

CEO
Quin
Anna Williamson, Senior Director, Business Development, Roche

Anna Williamson

Senior Director, Business Development
Roche
Rupert Winckler, Head of EMEA BD, Olympus Corporation

Rupert Winckler

Head of EMEA BD
Olympus Corporation
Jonathan Wood, Regional Director, Abbott Vascular

Jonathan Wood

Regional Director
Abbott Vascular
Claire Woodthorpe, VP, Europe & COO, Lightpoint Medical

Claire Woodthorpe

VP, Europe & COO
Lightpoint Medical
Donald Xu, Managing Partner, Lynx Financial

Donald Xu

Managing Director
Lynx Capital
Sarah Yusuf, Consultant Radiologists & Group Director, Sandwell and West Birmingham NHS Trust

Sarah Yusuf

Consultant Radiologists & Group Director
Sandwell and West Birmingham NHS Trust
Alexandra Zemp, Partner, McKinsey & Company

Alexandra Zemp

Partner
McKinsey & Company
Eyal Zimlichman, Chief Medical and Innovation Officer, Sheba Medical Centre

Eyal Zimlichman

Chief Innovation and Transformation Officer
Sheba Medical Centre
Klaas Zuideveld, CEO, Versameb

Klaas Zuideveld

CEO
Versameb
Marcel Zwaal, CEO, Gadeta

Marcel Zwaal

CEO
Gadeta
DOWNLOAD BROCHURE